Torrent Pharma Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
2,352.00
1,847.00
1,225.00
1,526.00
1,186.00
561.00
Adjustment
993.00
937.00
1,349.00
992.00
876.00
1,418.00
Changes In working Capital
418.00
-18.00
-351.00
-338.00
-385.00
99.00
Cash Flow after changes in Working Capital
3,764.00
2,766.00
2,224.00
2,180.00
1,676.00
2,079.00
Cash Flow from Operating Activities
3,266.00
2,368.00
1,802.00
2,005.00
1,392.00
1,798.00
Cash Flow from Investing Activities
-159.00
-2,335.00
-196.00
-443.00
229.00
-245.00
Cash Flow from Financing Activities
-2,779.00
77.00
-1,781.00
-1,650.00
-1,549.00
-1,314.00
Net Cash Inflow / Outflow
326.00
110.00
-174.00
-89.00
73.00
238.00
Opening Cash & Cash Equivalents
508.00
398.00
572.00
661.00
588.00
702.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
835.00
508.00
398.00
572.00
661.00
940.00
Compare Cash Flow Results of Torrent Pharma
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
2352.11
5896.72
-3,544.00
-60.11%
Adjustment
993.99
640.77
353.00
55.12%
Changes In working Capital
418.08
-806.1
1,224.00
151.86%
Cash Flow after changes in Working Capital
3764.18
5731.39
-1,967.00
-34.32%
Cash Flow from Operating Activities
3266.08
4133.91
-867.00
-20.99%
Cash Flow from Investing Activities
-159.83
-2982.47
2,823.00
94.64%
Cash Flow from Financing Activities
-2779.64
-1200.43
-1,579.00
-131.55%
Net Cash Inflow / Outflow
326.61
-48.99
374.00
766.69%
Opening Cash & Cash Equivalents
508.53
561.33
-53.00
-9.41%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
835.14
512.34
323.00
63.01%
Cash Flow - Snapshot (Consolidated) - Mar'24
YoY Growth in year ended Mar 2024 is 37.92% vs 31.34% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
3,266.08
2,368.13
37.92%